2Fang Y, Chen H, Li Y L, et al. Melioidosis in Hainan, China: a restrospective study[J]. Trans R Soc Trop Med Hyg, 2015, 109(10): 636-642.DOI: 10.1093/trstmh/trv065.
3Rholl D A, Papp-Wallace K M, Tomaras A P, et al. Molecular Investigations of PenA-mediated beta-lactam Resistance in Burkholderia pseudomallei[J]. Front Microbiol, 2011, 2: 139. DOI: 10.3389/fmicb.2011.00139.
4Podnecky N L, Rhodes K A, Schweizer H P. Efflux pump-mediated drug resistance in Burkholderia[J]. Front Microbiol, 2015, 6: 305. DOI: 10.3389/fmicb.2015.00305.
5Aunkham A, Schulte A, Winterhalter M, et al. Porin involvement in cephalosporin and carbapenem resistance of Burkholderia pseudomallei[J]. PLoS One, 2014, 9(5): e95918. DOI: 10.1371/journal.pone.0095918.
6Podnecky N L, Wuthiekanun V, Peacock S J, et al. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates[J]. Antimicrob Agents Chemother, 2013, 57(9): 4381-4386. DOI: 10.1128/AAC. 00660-13.
7Mongkolrob R, Taweechaisupapong S, Tungpradabkul S. Correlation between biofilm production, antibiotic susceptibility and exopolysaccharide composition in Burkholderia pseudomallei bpsI, ppk, and rpoS mutant strains[J]. Microbiol Immunol, 2015, 59(11): 653-663. DOI: 10. 1111/1348-0421.12331.
8Khosravi Y, Vellasamy K M, Mariappan V, et al. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients[J]. ScientificWorldJournal, 2014, 2014: 132971. DOI: 10.1155/2014/132971.
9Chantratita N, Rholl D A, Sim B, et al. Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei[J]. Proc Natl Acad Sci U S A, 2011, 108(41): 17165-17170. DOI: 10.1073/pnas. 1111020108.
10Dance D A, Davong V, Soeng S, et al. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei[J]. Int J Antimicrob Agents, 2014, 44(4): 368-369. DOI: 10.1016/j.ijantimicag.2014.06.003.
